2012 Drug Pipeline : R&D turns to specialty therapies with less generic exposure Cardiometabolic Disease (Part 1) : The pharmacist’s tools for managing dyslipidemia and hypertension Rehabilitating the impaired pharmacist DeKalb and Walgreens discharge med service
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.